For the Inventor, By the Inventor

Enter assignee name

San Francisco, CA, United States of America

Atlasmedx, Inc.

USPTO Granted Patents = 3

EPO Patents = 1

Forward Citations = 1

Loading Chart...

Loading Chart...

4 inventors (with patents filed for the assignee):

David Jablons (3 out of 24 patents)

Hassan Lemjabbar-Alaoui (3 out of 6 patents)

Tsze Tsang (3 out of 33 patents)

4. Csaba J Peto (3 out of 26 patents)

5. David M Jablons (0 patent)

3 patents: Sort by Forward Citations

1. 12145925 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer (2024-11-19),

2. 11072600 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer (2021-07-27),

3. 10640493 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer (2020-05-05),

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

3 Patents

#1,026 in San Francisco, CA

#16,426 in California

#72,030 in US

San Francisco, CA, United States of America

Atlasmedx, Inc.

Forward Citations = 1

4 inventors:

David Jablons (3 out of 24 patents)

Hassan Lemjabbar-Alaoui (3 out of 6 patents)

Tsze Tsang (3 out of 33 patents)

4. Csaba J Peto (3 out of 26 patents)

5. David M Jablons (0 patent)

Please report any incorrect information to support@idiyas.com

Loading…